Erlotinib Treatment in Colorectal Cancer Suppresses Autophagy Based on <i>KRAS</i> Mutation.

Siegman, Alexander; Shaykevich, Aaron; Chae, Danbee; Silverman, Isaac; Goel, Sanjay; Maitra, Radhashree

Erlotinib Treatment in Colorectal Cancer Suppresses Autophagy Based on KRAS Mutation.

Siegman, Alexander; Shaykevich, Aaron; Chae, Danbee; Silverman, Isaac; Goel, Sanjay; Maitra, Radhashree.

Afiliação

Siegman A; Department of Biology, Yeshiva University, New York, NY 10033, USA.
Shaykevich A; Department of Biology, Yeshiva University, New York, NY 10033, USA.
Chae D; Department of Biology, Yeshiva University, New York, NY 10033, USA.
Silverman I; Department of Biology, Yeshiva University, New York, NY 10033, USA.
Goel S; Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA.
Maitra R; Department of Biology, Yeshiva University, New York, NY 10033, USA.

Curr Issues Mol Biol ; 46(7): 7530-7547, 2024 Jul 16.

Article em En | MEDLINE | ID: mdl-39057088

Palavras-chave

EGFR; KRAS; autophagy; cancer; colorectal; erlotinib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Curr Issues Mol Biol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google